Kelyniam Global (OTC:KLYG) Stock, Quote.Headers.trade-ideas

Kelyniam Global Inc engaged in the rapid production of custom prosthetic cranial implants utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. The Company develops, manufactures, and distributes custom cranial and maxilla-facial implants for patients requiring the reconstruction of cranial and certain facial structures. The Company's business operations consist of regulatory approvals, manufacturing operations and distribution to customers and markets in the United States.

News

KLYG

KLYG Receives FDA Clearance To Market Cranial Implant (KLYG)

KELYNIAM GLOBAL INC by Kelyniam Global, Inc.

Kelyniam Global Inc

Earnings

Small Cap

Press Releases

Kelyniam Global Releases Strong Q2 Financials

Kelyniam Global Releases Q3 Financials, Strong Performance Continues

Offerings

Kelyniam Global, Inc., ("KLYG") Announces Private Investment to Public Entity ("PIPE") Closure of Securities Offering

Short Sellers

Kelyniam Corporate Update

KELYNIAM ACHIEVES RECORD REVENUE & PROFITABILITY FOR 2024

Contracts

Kelyniam Global Announces Q1 2025 Financial Results and Strategic Partnership

Kelyniam Global

Comments

Kelyniam Global

Kelyniam Global (OTC:KLYG) Stock, Quote.Headers.trade-ideas

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell